AMGEN

Lobbying client · District of Columbia · filed 2025 to 2026

Manufacture Pharmaceuticals

$136,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (66449), not by name.

Firms hired 1

MR. DAN CRIPPEN $136,000 4 filings

Reported by year 2 years

2026 $0 1 filing
2025 $136,000 3 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 1

Recent filings 4 total

Q2Y

MR. DAN CRIPPEN

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 28, 2026

View → Q4

MR. DAN CRIPPEN

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $100,000 income · posted Feb 18, 2026

View → Q3

MR. DAN CRIPPEN

3rd Quarter (July 1 - Sep 30) 2025 · House · $36,000 income · posted Oct 1, 2025

View → RR

MR. DAN CRIPPEN

2nd Quarter (Apr 1 - June 30) 2025 · posted May 7, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.